Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost C van den Born

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Nephrology and Hypertension|January 26, 2016
Hydrogen sulfide in hypertensionHarry van Goor, Joost C van den Born, Jan-Luuk Hillebrands, et al.
Diabetes|January 23, 2016
Gasotransmitters in Vascular Complications of DiabetesJoost C van den Born, Hans-Peter Hammes, Wolfgang Greffrath, et al.
Nitric Oxide : Biology and Chemistry|March 9, 2016
High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetesJoost C van den Born, Anne-Roos S Frenay, Stephan J L Bakker, et al.
Kidney360|March 19, 2026
Early Lymphoid Aggregates in Protocol Kidney Allograft Biopsies: Molecular Characterization and Association with Long-Term Kidney Allograft OutcomeRomy du Long, Nike Claessen, Frederike J Bemelman, et al.
Frontiers in Immunology|April 22, 2024
Memory B-cell derived donor-specific antibodies do not predict outcome in sensitized kidney transplant recipients: a retrospective single-center studyDania Altulea, Joost C van den Born, Arjan Diepstra, et al.
Plos One|May 16, 2013
Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolismPauline M Snijder, Rudolf A de Boer, Eelke M Bos, et al.
Antioxidants & Redox Signaling|June 16, 2018
Urinary Excretion of Sulfur Metabolites and Risk of Cardiovascular Events and All-Cause Mortality in the General PopulationJoost C van den Born, Anne-Roos S Frenay, Anne M Koning, et al.
Transplantation|August 31, 2023
Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO TrialJoost C van den Born, Soufian Meziyerh, Priya Vart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 7, 2025
Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney DiseaseWisanne M Bakker, Hiddo J L Heerspink, Stefan P Berger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Nephrology and Hypertension|January 26, 2016
Hydrogen sulfide in hypertensionHarry van Goor, Joost C van den Born, Jan-Luuk Hillebrands, et al.
Diabetes|January 23, 2016
Gasotransmitters in Vascular Complications of DiabetesJoost C van den Born, Hans-Peter Hammes, Wolfgang Greffrath, et al.
Nitric Oxide : Biology and Chemistry|March 9, 2016
High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetesJoost C van den Born, Anne-Roos S Frenay, Stephan J L Bakker, et al.
Kidney360|March 19, 2026
Early Lymphoid Aggregates in Protocol Kidney Allograft Biopsies: Molecular Characterization and Association with Long-Term Kidney Allograft OutcomeRomy du Long, Nike Claessen, Frederike J Bemelman, et al.
Frontiers in Immunology|April 22, 2024
Memory B-cell derived donor-specific antibodies do not predict outcome in sensitized kidney transplant recipients: a retrospective single-center studyDania Altulea, Joost C van den Born, Arjan Diepstra, et al.
Plos One|May 16, 2013
Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolismPauline M Snijder, Rudolf A de Boer, Eelke M Bos, et al.
Antioxidants & Redox Signaling|June 16, 2018
Urinary Excretion of Sulfur Metabolites and Risk of Cardiovascular Events and All-Cause Mortality in the General PopulationJoost C van den Born, Anne-Roos S Frenay, Anne M Koning, et al.
Transplantation|August 31, 2023
Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO TrialJoost C van den Born, Soufian Meziyerh, Priya Vart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 7, 2025
Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney DiseaseWisanne M Bakker, Hiddo J L Heerspink, Stefan P Berger, et al.
Pageof 1